As GLP-1 Care Enters Its Second Act, T·TIME Launches Fixed-Rate Cash-Pay ProgramCompounded semaglutide and tirzepatide program keeps the same rate when the prescribed dose changes - a model built around the less glamorous part of the GLP-1 story: staying on treatment.
T·TIME Launches Fixed-Rate Cash-Pay Program for Compounded Semaglutide and TirzepatideAUSTIN, TX / ACCESS Newswire / September 23, 2026 / T·TIME has launched a cash-pay telehealth program for compounded injectable semaglutide and tirzepatide.
